Researchers from China developed a new nomogram that can predict the levels of nonceruloplasmin bound copper in the serum. According to the researchers, the nomogram could be useful in clinical practice and delay the progression of Wilson disease as well as improve clinical prognosis. The nomogram identified independent predictors for ideal serum levels of nonceruloplasmin bound copper in WD as being the age of the patient at diagnosis, the clinical classification of the disease, laminin, liver stiffness measurement, and copper to zinc ratio in 24-hour urinary excretions. Read more: https://brnw.ch/21wEBEr #RareDisease
